Ambulero
Pre-clinicalAmbulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.
Founded
2020
Focus
RNA & Gene TherapyCell & Gene Therapy
About
Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.
Funding History
3Total raised: $21M
Series A$12MSolas BioVenturesOct 15, 2023
Seed$6MUniversity of MiamiAug 15, 2022
Seed$3MUndisclosedApr 15, 2022
Company Info
TypePrivate
Founded2020
LocationMiami, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile